10.
Ryan RE (1984) Comparative study of nadolol and propranolol in prophylactic treatment of migraine. Am Heart J 108:1156–1159
11.
Cortelli P, Sacquegna T, Albani F, Baldrati A, D’Alessandro R, Baruzi A, Lugaresi E et al (1985) Propranolol plasma levels and relief of migraine. Arch Neurol 42:46–48
12.
Koella WP (1985) CNS-related side-effects of b-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol 28:55–63
13.
Andersson K, Vinge E (1990) Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 39:355–373
14.
Ramadan NM (2004) Prophylactic migraine therapy: mechanisms and evidence. Curr Pain Headache Rep 8:91–95
15.
Tfelt-Hansen P, Standnes B, Kangasniemi P et al (1984) Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 69:1–8
16.
Sudilovsky A, Elkind AH, Ryan RE et al (1987) Comparative efficacy of nadolol and propranolol in the management of migraine. Headache 27:421–426
17.
Andersson PG, Dahl S, Hansen JH et al (1983) Prophylactic treatment of classical and non-classical migraine with metoprolol–a comparison with placebo. Cephalalgia 3:207–212
18.
Kangasniemi P, Hedman C (1984) Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia 4:91–96
19.
Olsson JE, Behring HC, Forssman B et al (1984) Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand 70:160–168
20.
Diener HC, Hartung E, Chrubasik J et al (2001) A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 21:120–128
21.
Johannsson V, Nilsson LR, Widelius T et al (1987) Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 27:372–374
22.
van de Ven LL, Franke CL, Koehler PJ (1997) Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 17:596–599
23.
Ryan RE, Sudilovsky A (1983) Nadolol: its use in the prophylactic treatment of migraine. Headache 23:26–31
24.
Sudilovsky A, Stern MA, Meyer JH (1986) Nadolol: the benefits of adequate trial duration in the prophylaxis of migraine. Headache 26:325
25.
Stellar S, Ahrens SP, Meibohm AR et al (1984) Migraine prevention with timolol. A double-blind crossover study. JAMA 252:2576–2580
26.
Schoenen J, Maertens de Noordhout A, Timsit-Berthier M et al (1986) Contingent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia 6:229–233
27.
Maertens de Noordhout A, Timsit-Berthier M, Timsit M et al (1987) Effects of beta blockade on contingent negative variation in migraine. Ann Neurol 21:111–112
28.
Sándor PS, Áfra J, Ambrosini A et al (2000) Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 40:30–35
29.
Silberstein SD, Neto W, Schmitt J et al (2004) Topiramate in the prevention of migraine headache: a randomized, double-blind, placebo-controlled, multiple-dose study. For the MIGR-001 Study Group. Arch Neurol 61:490–495
30.
Brandes JL, Saper JR, Diamond M et al (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA 291:965–973
31.
Diener HC, Tfelt-Hansen P, Dahlof C et al (2004) Topiramate in migraine prophylaxis–results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943–950
32.
Bussone G, Diener HC, Pfeil J et al (2005) Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomized controlled trials. Int J Clin Pract 59:961–968
33.
Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81–84
34.
Jensen R, Brinck T, Olesen J (1994) Sodium valproate has prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 44:241–244
35.
Freitag FG, Collins SD, Carlson HA et al (2003) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. For the Depakote ER Migraine Study Group. Neurology 58:1652–1659
36.
Klapper JA (1997) Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17:103–108
37.
Silberstein SD (1996) Divalproex sodium in headache–literature review and clinical guidelines. Headache 36:547–555
38.
Mathew NT, Saper JR, Silberstein SD et al (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281–286
39.
Mathew NT, Saper JR, Silberstein SD et al (1995) Prophylaxis of migraine headaches with divalproex sodium. Arch Neurol 52:281–286
40.
Pellock JM, Willmore LJ (1991) A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 41:961–964
41.
Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109–112
42.
Gupta P, Singh S, Goyal V et al (2007) Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp Study). Headache 47:402–412
43.
Mathew NT, Rapoport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119–128
44.
Mulleners WM, McCrory DC, Linde M (2015) Antiepileptics in migraine prophylaxis: an updated Cochrane review. Cephalalgia 35:51–62
45.
< div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register to continue
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
